Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,145 | 1,923 | 2,390 | 2,899 | 3,664 |
| Receivables | 482 | 312 | 369 | 186 | 221 |
| TOTAL | $1,775 | $2,304 | $2,797 | $3,134 | $3,885 |
| Non-Current Assets | |||||
| PPE Net | 328 | 314 | 341 | 380 | 418 |
| Other Non-Current Assets | 146 | 126 | 107 | 103 | 100 |
| TOTAL | $474 | $440 | $448 | $483 | $518 |
| Total Assets | $2,249 | $2,744 | $3,245 | $3,617 | $4,403 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 451 | 385 | 253 | 681 | 1,610 |
| Accrued Expenses | 839 | 750 | 555 | 595 | N/A |
| TOTAL | $1,290 | $1,135 | $808 | $1,276 | $1,610 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 142 | 121 | 101 | 94 | 127 |
| TOTAL | $142 | $121 | $101 | $94 | $127 |
| Total Liabilities | $1,432 | $1,256 | $909 | $1,370 | $1,737 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 572 | 563 | 559 | 548 | 536 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -44,950 | -44,078 | -42,656 | -41,962 | -40,865 |
| TOTAL | $817 | $1,488 | $2,336 | $2,247 | $2,666 |
| Total Liabilities And Equity | $2,249 | $2,744 | $3,245 | $3,617 | $4,403 |